Aarti Pharmalabs Ltd. - Research Center
543748 AARTIPHARM Group (A) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Sales |
714.28 |
777.65 |
Operating profit |
150.55 |
158.98 |
Interest |
7.85 |
9.57 |
Gross profit |
147.56 |
150.65 |
EPS (Rs) |
9.87 |
10.28 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Other income |
4.86 |
1.24 |
Stock adjustment |
-25.40 |
-73.26 |
Raw material |
390.52 |
494.88 |
Power and fuel |
- |
- |
Employee expenses |
61.37 |
58.33 |
Excise |
- |
- |
Admin and selling expenses |
- |
- |
Research and development expenses |
- |
- |
Expenses capitalised |
- |
- |
Other expenses |
137.24 |
138.72 |
Provisions made |
- |
- |
Depreciation |
31.76 |
26.96 |
Taxation |
26.36 |
30.50 |
Net profit / loss |
89.44 |
93.19 |
Extra ordinary item |
- |
- |
Prior year adjustments |
- |
- |
Equity capital |
45.31 |
45.31 |
Equity dividend rate |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
OPM (%) |
21.08 |
20.44 |
GPM (%) |
20.52 |
19.34 |
NPM (%) |
12.44 |
11.96 |